Kimberly J. Popovits holds a significant position as a director at 10x Genomics, owning shares in the company since her appointment. In her early years, she reported substantial financial rewards as she transitioned from Genomic Health, where she gained her...

Kimberly J. Popovits holds a significant position as a director at 10x Genomics, owning shares in the company since her appointment. In her early years, she reported substantial financial rewards as she transitioned from Genomic Health, where she gained her wealth through stock options and performance-based pay. However, her current holdings in 10x Genomics have likely fluctuated as she has not been awarded stock or bonuses recently, illustrating her unique focus on long-term company performance rather than immediate financial gain. As of now, her compensation reflects a strategic approach, possibly awaiting the right moment to align her holdings with the company's growth, especially with the fast-evolving market in genomics. Investors are keenly interested in how she will leverage her experience and holdings in charting 10x's future.